feed,title,long_url,short_url
Preprints,Potential Benefit of Early Treatment with Sotrovimab in Patients With High Risk for Severe COVID-19 Carrying BA.2 Infection,https://www.preprints.org/manuscript/202207.0223/v1,https://bit.ly/3o2ae4k
